<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36164285</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7074</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>International journal of general medicine</Title><ISOAbbreviation>Int J Gen Med</ISOAbbreviation></Journal><ArticleTitle>A Comprehensive Assessment of Self-Reported Post COVID-19 Symptoms Among Beneficiaries of Hospital Employee Scheme at a Tertiary Healthcare Institution in Northern India.</ArticleTitle><Pagination><StartPage>7355</StartPage><EndPage>7372</EndPage><MedlinePgn>7355-7372</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IJGM.S381070</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">With millions of people being affected by COVID-19, people living with post COVID-19 clinical symptoms (PCS) are expected to rise further. The primary aim of the study was to comprehensively assess self-reported PCS and its associated risk factors among beneficiaries of Hospital Employee Scheme of a tertiary healthcare institution in Delhi.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">An online cross-sectional study was conducted using a semi-structured questionnaire developed by employing nominal group technique among individuals aged 18 years and above who were novel SARS-CoV-2 positive from January to April 2021. Participants were telephoned first, before sending the online survey link. Socio-demographic data, information on PCS along with potential risk factors, pre-existing morbidities, vaccination status, severity of acute illness and management were collected between June and July 2021. PCS was presented as relative frequency; Chi-Square test and odds ratio; adjusted values were used to rule out any association between PCS and predictors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In total, 773 of 1801 eligible participants responded to the survey (completion rate 42.9%), with a median age of 34 years (IQR 27-44). Males accounted for 56.4% and PCS was present in 33.2%. The most prevalent symptoms were fatigue (79.3%), arthralgia (33.4%), myalgia (29.9%), hair loss (28.0%), headache (27.2%), breathlessness (25.3%), and sleep disturbance (25.3%). The prevalence of PCS was reduced to 12.8% at 12 weeks. Female gender, older age, oxygen supplementation, severity of acute illness, and pre-existing co-morbidities were positively associated with PCS. Vaccination (second dose) reduced the odds of developing PCS by 39% compared to unvaccinated participants (aOR 0.61; 95% CI 0.40-0.96).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">PCS affects almost all organ systems of the body, regardless of the severity of acute COVID-19 illness. Two doses of vaccine hel reduce the development of PCS.</AbstractText><CopyrightInformation>&#xa9; 2022 Senjam et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Senjam</LastName><ForeName>Suraj Singh</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0001-8204-3669</Identifier><AffiliationInfo><Affiliation>Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balhara</LastName><ForeName>Yatan Pal Singh</ForeName><Initials>YPS</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Pameshwar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nischal</LastName><ForeName>Neeraj</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manna</LastName><ForeName>Souvik</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8870-8542</Identifier><AffiliationInfo><Affiliation>Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madan</LastName><ForeName>Karan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Critical Care and Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Nishat Hussain</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Noopur</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vashist</LastName><ForeName>Praveen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guleria</LastName><ForeName>Randeep</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Critical Care and Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Int J Gen Med</MedlineTA><NlmUniqueID>101515487</NlmUniqueID><ISSNLinking>1178-7074</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Northern India</Keyword><Keyword MajorTopicYN="N">cross-sectional study</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">post COVID-19 symptoms</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interests in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>1</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36164285</ArticleId><ArticleId IdType="pmc">PMC9509009</ArticleId><ArticleId IdType="doi">10.2147/IJGM.S381070</ArticleId><ArticleId IdType="pii">381070</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization Group. WHO Director-General&#x2019;s opening remarks at the media briefing on COVID-19-11 March 2020; 2021. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-The-media-briefing-on-covid-19&#x2014;11-march-2020. Accessed September
9, 2022.</Citation></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727&#x2013;733. doi:10.1056/NEJMoa2001017</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Group. WHO coronavirus (COVID-19) dashboard WHO coronavirus (COVID-19) dashboard with vaccination data. 2021. Available from: https://covid19.who.int/?gclid=CjwKCAjwq7aGBhADEiwA6uGZp3UkD5DGqIpskR3VpX8_BPylwnRJuBp60kNBfL6v_bCKnWXCqLSbuxoCdioQAvD_BwE. Accessed September
9, 2022.</Citation></Reference><Reference><Citation>The Government of India. IndiaFightsCorona COVID-19 in India, Corona Virus Tracker mygov.in; 2020. Available from: https://www.mygov.in/covid-19. Accessed September
9, 2022.</Citation></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Bitna-Ha KSW, Chang HH, et al. Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect Dis. 2022;22(1). doi:10.1186/s12879-022-07062-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07062-6</ArticleId><ArticleId IdType="pmc">PMC8793328</ArticleId><ArticleId IdType="pubmed">35086489</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekstr&#xf6;m S, Andersson N, L&#xf6;vquist A, et al. COVID-19 among young adults in Sweden: self-reported long-term symptoms and associated factors. Scand J Public Health. 2022;50(1):85&#x2013;93. doi:10.1177/14034948211025425</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14034948211025425</ArticleId><ArticleId IdType="pmc">PMC8808012</ArticleId><ArticleId IdType="pubmed">34148461</ArticleId></ArticleIdList></Reference><Reference><Citation>Velumani A, Nikam C, Suraweera W, et al. SARS-CoV-2 seroprevalence in 12 cities of India from July&#x2013;December 2020. medRxiv. 2021. doi:10.1101/2021.03.19.21253429</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.19.21253429</ArticleId></ArticleIdList></Reference><Reference><Citation>Google forms: free online surveys for personal use. 2021; Available from: https://www.google.com/forms/about/. Accessed September
9, 2022.</Citation></Reference><Reference><Citation>Karag&#xf6;z MA, G&#xfc;l A, Borg C, et al. Influence of COVID-19 pandemic on sexuality: a cross-sectional study among couples in Turkey. Int J Impot Res. 2020;1&#x2013;9. doi:10.1038/s41443-020-00378-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41443-020-00378-4</ArticleId><ArticleId IdType="pmc">PMC7739794</ArticleId><ArticleId IdType="pubmed">33328620</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer B, Walsh CM, Gondwe L, Reynolds K, Lawrence E, Kasiya A. WhatsApp as a medium to collect qualitative data among adolescents: lessons learned and considerations for future use. Gates Open Res. 2020;4:130. doi:10.12688/gatesopenres.13169.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/gatesopenres.13169.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Eysenbach G. Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. doi:10.2196/jmir.6.3.e34</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.6.3.e34</ArticleId><ArticleId IdType="pmc">PMC1550605</ArticleId><ArticleId IdType="pubmed">15471760</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi:10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15(3):869&#x2013;875. doi:10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122. doi:10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MA, Hossain KMA, Saunders K, et al. Prevalence of long COVID symptoms in Bangladesh: a prospective inception cohort study of COVID-19 survivors. medRxiv. 2021. doi:10.1136/bmjgh-2021-006838</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-006838</ArticleId><ArticleId IdType="pmc">PMC8671853</ArticleId><ArticleId IdType="pubmed">34906986</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75(3). doi: 10.1111/ijcp.13746</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal A, Iqbal K, Arshad Ali S, et al. The COVID-19 sequelae: a cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of COVID-19 survivors. Cureus. 2021;13(2). doi:10.7759/cureus.13080</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.13080</ArticleId><ArticleId IdType="pmc">PMC7932827</ArticleId><ArticleId IdType="pubmed">33680620</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;383. doi:10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahad MI, Kyle L, Viknesh S, Jonathan MC, Hutan A, Ara D. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;36. doi:10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.686029</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Galal I, Hussein RM, Amin MT, et al. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchol. 2021;15(1):1&#x2013;8. doi:10.1186/s43168-020-00049-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-020-00049-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima G, Bhatt D, Idrees J, Khalid B, Mahdi F, Mehdi F. Elucidating post-COVID-19 manifestations in India. medRxiv. 2021. doi:10.1101/2021.07.06.21260115</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.06.21260115</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao GV, Gella V, Radhakrishna M, et al. Post-COVID-19 symptoms are not uncommon among recovered patients-A cross-sectional online survey among the Indian population. medRxiv. 2021. doi:10.1101/2021.07.15.21260234</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.15.21260234</ArticleId><ArticleId IdType="pmc">PMC9200210</ArticleId><ArticleId IdType="pubmed">35488693</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;6. doi:10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z, Yang M, Lai C-L. Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines. 2021;9(8):966. doi:10.3390/biomedicines9080966</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080966</ArticleId><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2021;22:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin A, Davison J, Tarrant R, et al. A multidisciplinary NHS COVID-19 service to manage post-COVID-19 syndrome in the community. J Prim Care Community Health. 2021;12:215013272110109. doi:10.1177/21501327211010994</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211010994</ArticleId><ArticleId IdType="pmc">PMC8064663</ArticleId><ArticleId IdType="pubmed">33880955</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>